Long Tail Secures Growth Investment for AI Healthcare Platform
Long Tail, a Chicago-based healthcare technology company, has received a strategic growth investment from Eir Partners Capital to expand its AI platform for utilization management and physician advisory services. Financial terms were not disclosed.
The company, founded in 2023, builds software that helps hospitals and health systems reduce claim denials and improve reimbursement outcomes. Its platform aggregates insights from a network of providers and physicians to help organizations understand payer behavior and optimize revenue cycle performance.
What Long Tail Does
Long Tail targets utilization management, a major source of high-cost claim denials in healthcare operations. The platform uses proprietary payer intelligence and AI-driven automation to streamline denial workflows and cut operational costs.
The company collects data from its growing provider network to help health systems predict payer decisions and adjust their strategies accordingly.
The Investment
Eir Partners Capital, a Miami-based private equity firm focused on healthcare technology, will support Long Tail's product development, expansion of its data network, and sales efforts. The firm typically invests in growth-stage companies across the payer, provider, employer, and pharmaceutical sectors.
Jeff Means, Long Tail's CEO and co-founder, said the investment validates the company's strategy and market position. Brett Carlson, Eir Partners' founder and CEO, said utilization management remains an undertapped market with significant financial impact on health systems.
For executives evaluating AI for Healthcare investments, Long Tail's funding reflects growing interest in AI applications that directly address operational efficiency and revenue performance. Understanding how these platforms work is essential for strategy teams making decisions about healthcare technology spending.
Your membership also unlocks:
